Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Moodys
McKinsey
Harvard Business School
Boehringer Ingelheim

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Litigation Details for Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Docket   Start Trial Date Filed 2018-07-13
Court District Court, D. Delaware Date Terminated 2019-03-19
Cause 35:1 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties ACTAVIS ELIZABETH LLC; NOVARTIS PHARMACEUTICALS CORPORATION; TEVA PHARMACEUTICALS USA, INC.
Patents 9,187,405
Attorneys Amanda J. Hollis; Andrew Blythe; Benjamin A. Smyth; Daniel M. Silver; Gregory Springsted; James H. McConnell; Jane M. Love; Jay P. Lefkowitz; Karen Elizabeth Keller; Michael P. Kelly; Nathan Roger Hoeschen; Sarah Tsou
Firms Shaw Keller LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 39 Consolidated Invalidity Contentions Regarding U.S. Patent No. 9,187,405 filed by HEC Pharm Co., Ltd., HEC Pharm …2018 19 March 2019 1:18-cv-01039 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 4 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,187,405. (rwc) (Entered: 07…2018 19 March 2019 1:18-cv-01039 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 43 Consolidated Invalidity Contentions Regarding U.S. Patent No. 9,187,405 filed by Mylan Pharmaceuticals, Inc..(Ewing…2018 19 March 2019 1:18-cv-01039 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Colorcon
Dow
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.